SCHEMBL25003142

SCHEMBL25003142

CC(C)Oc1ccc(-c2nccc(C(=O)NN)n2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.53
▸ KMT2A Q03164 3/20 0.47
▸ MAPT P10636 3/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KDM4E B2RXH2 2/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.47
▸ XDH P47989 3/20 0.46
▸ LMNA P02545 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ ACACB O00763 2/20 0.44
▸ FDPS P14324 1/20 0.44
▸ PARP10 Q53GL7 1/20 0.43
▸ MCL1 Q07820 1/20 0.42
▸ POLB P06746 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ ALPL P05186 1/20 0.41
▸ ALPI P09923 1/20 0.41
▸ ALPG P10696 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25003826 0.85 CA1 (0.54) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL25002900 0.84 KMT2A (0.51) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL25003126 0.84 ALDH1A1 (0.51) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL25003134 0.82 NPC1 (0.51) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL25003794 0.82 PLK1 (0.49) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL25003138 0.82 FDPS (0.57) ALDH1A1MAPTSMN1; SMN2LMNATP53
SCHEMBL25003153 0.80 KMT2A (0.48) KMT2AMEN1KDM4ESMN1; SMN2NPC1
SCHEMBL25003131 0.78 MAP4K4 (0.55) ALDH1A1KMT2AMAPTMEN1KDM4E
SCHEMBL25003790 0.78 SCN9A (0.54) MCL1
SCHEMBL25003136 0.77 SCN10A (0.50) ALDH1A1KMT2AMAPTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010192-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 — — WO disclosed
Send feedback